Cumulative glycemic exposure and microvascular complications in insulin- dependent diabetes mellitus: The glycemic threshold revisited

Archives of Internal Medicine

Volumn 157, Issue 16, 1997, Pages 1851-1856

  Orchard, Trevor J ^a,b   Forrest, Kimberly Y Z ^a   Ellis, Demetrius ^b   Becker, Dorothy J ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CALCULATION; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREDICTION; PRIORITY JOURNAL;

EID: 0030848518     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.16.1851     Document Type: Article

References (27)

1. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;332:1251-1255.
2. Danne T, Enders I, Weber B, Burger W, Hartmann R, Hovener G. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Diabetes Care. 1994;17:1390-1396.
3. Warram JH, Manson JE, Krolewski AS. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med. 1995;332: 1305-1306.
4. 1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968-983.
5. The EURODIAB IDDM Complications Study. Microvascular and acute complications in IDDM patients. Diabetologia. 1994;37:278-285.
6. Chaturvedi N, Fuller JH. Glycosylated hemoglobin and the risk of microalbuminuria in insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:940-941.
7. Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration. Diabetes. 1990;39:1116-1124.
8. Orchard TJ, Dorman JS, Maser RE, et al. Factors associated with avoidance of severe complications after 25 years of IDDM. Diabetes Care. 1990;13:741-747.
9. Wagener DK, Sacks JM, LaPorte RE, MacGregor JM. The Pittsburgh Study of insulin-dependent diabetes mellitus. Diabetes. 1982;31:136-44.
10. Ellis D, Buffone GJ. New approach to evaluation of proteinuric states. Clin Chem. 1977;23:666-679.
11. Ellis D, Becker DJ. Editorial reply. J Pediatr. 1984;104:324-325.
12. Ellis D, Coonrod BA, Dorman JS, Kelsey SF, Avner EB, Orchard TJ. Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis. 1989;4:321-328.
13. Early Treatment of Diabetic Retinopathy Study Coordinating Center: Manual of Operations. Baltimore: University of Maryland School of Medicine; 1980:chap 5 and 18.
14. DCCT Research Group. DCCT Research Group Manual of Operations for the Diabetes Control and Complications Trial. Washington, DC: US Dept of Commerce; 1987.
15. Maser RE, Nielsen VK, Bass EB, et al. Measuring diabetic neuropathy. Diabetes Care. 1989;12:270-275.
16. Ulm K. A statistical method for assessing a threshold in epidemiological studies. Stat Med. 1991;10:341-349.
17. Viberti G, Yip-Messent J, Morocutti A. Diabetic nephropathy. Diabetes Care. 1992; 15:1216-1225.
18. Krolewski AS, Canessa M, Warram JH, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:140-145.
19. Coonrod BA, Ellis D, Becker DJ, et al. Predictors of microalbuminuria in individuals with insulin-dependent diabetes mellitus. Diabetes Care. 1993;16:1-8.
20. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevold-Sen A. Albuminuria reflects widespread vascular damage: the stenohypothesis. Diabetologia. 1989;32:219-226.
21. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications. Diabetes. 1996;45:1289-1298.
22. 1c for the effect of hyperglycemia on the risk of diabetic microangiopathy. Diabetes Care. 1996; 19:183.
23. Schmidt HHJ, Hill S, Makarion EV, Fenerstein IM, Dugi KA, Hoeg JM. Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol. 1996;77:575-580.
24. D'Antonio JA, Ellis D, Doft BH, et al. Diabetes complications and glycemic control. Diabetes Care. 1989;12:694-700.
25. Lloyd CE, Becker DJ, Wolfson SK, Ellis D, Orchard TJ. The incidence of complications in insulin-dependent diabetes mellitus: a survival analysis. Am J Epidemiol. 1996;143:431-441.
26. Lloyd CE, Kuller LH, Becker DJ, Ellis D, Wing RR, Orchard TJ. Coronary artery disease in IDDM. Arterioscler Thromb Vasc Biol. 1996;16:720-726.
27. American Diabetes Association. Standards of medical care for patients with diabetes mellitus: position statement. Diabetes Care. 1997;20(suppl):S5-S13.